Developing Explicit Positive Beers Criteria for Preferred Central Nervous System Medications in Older Adults

Printer-friendly versionPrinter-friendly version

Stefanacci RG, Cavallero E, Beers MH, Fick DM

Access the full text of this article
(You'll need to log on as a member first).



Background: The Beers criteria have been extensively used over the past decade to identify and evaluate potentially inappropriate medication use in adults 65 years of age and older in the United States. In contrast to the Beers criteria, the purpose of this pilot initiative was to develop a new set of explicit criteria for determining preferred (rather then potentially inappropriate) medications to use in older adults, using similar methodology as used in the three iterations of the Beers criteria. This initiative organized its evaluations around classes of medications that are both frequently used and associated with drug-related problems in older adults—central nervous system (CNS) medications.

Methods: This pilot study used a modified Delphi method -- a set of procedures and methods for reaching group consensus for a subject matter in which precise information is lacking -- to determine medications that are preferred for use in persons 65 years of age or older known to have specific medical conditions. Medications were selected as preferred because they are both effective, based upon a thorough evaluation of the clinical evidence, and pose less risk for older persons compared with alternative medications for the condition. Expert panelists evaluated 78 individual medications within four medical conditions (dementia, depression, Parkinson’s disease, and psychosis).

Results: This study identified 13 preferred medications to be used in older adults with these conditions.

Conclusions: This study expands explicit criteria to more precisely define preferred medication use in older adults. This refinement of the Beers criteria will enable providers to select medications with the greatest benefit-to-risk ratio for older adults, thereby minimizing drug-related problems. These criteria will need to be expanded to include other medication classes and medical conditions frequently encountered in older adults.

Keywords: Beers criteria, Central nervous system, Dementia, Depression, Older adults, Parkinson’s disease, Preferred medications, Psychosis.

Abbreviations: AHRQ = Agency for Healthcare Research and Quality, CER = Guide to Conducting Comparative Effectiveness Reviews, CMS = Centers for Medicare & Medicaid Services, CNS = Central nervous system, PDP = Prescription drug plan, PIM = Potentially inappropriate medications.

Consult Pharm 2009;24:601-10

The August 2009 issue of The Consultant Pharmacist contains the print version of this article: "Developing Explicit Positive Beers Criteria for Preferred Central Nervous System Medications in Older Adults" (Consult Pharm 2009;24:601-10).  The print version contained errors in Tables 3 and 4. The electronic version of the article available here is the corrected version. We regret the errors.

User login


To prevent automated spam submissions leave this field empty.
Become a Member Today ASCP

Shop Our Store

Education Courses Offered